The therapeutic role of oral tolerance in dextran sulfate sodium-induced colitis via Th1-Th2 balance and γδ T cells

Journal of Digestive Diseases

Volumn 14, Issue 10, 2013, Pages 543-551

  Yue, Min ^a   Shen, Zhe ^a   Yu, Chao Hui ^a   Ye, Hua ^a   Li, You Ming ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

T cell; Dextran sulfate; Inflammatory bowel disease; Oral tolerance; T lymphocytes

Indexed keywords

DEXTRAN SULFATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLITIS; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DISEASE ACTIVITY; GAMMA DELTA T LYMPHOCYTE; HISTOPATHOLOGY; INGESTION; MALE; MOUSE; NONHUMAN; ORAL TOLERANCE; PEYER PATCH; PHYSICAL TOLERANCE; PRIORITY JOURNAL; TH1 TH2 BALANCE;

DEXTRAN SULFATE; INFLAMMATORY BOWEL DISEASE; ORAL TOLERANCE; T-LYMPHOCYTES; ΓΔ T CELL;

ADMINISTRATION, ORAL; ANIMALS; AUTOANTIGENS; COLITIS, ULCERATIVE; COLON; DEXTRAN SULFATE; IMMUNE TOLERANCE; IMMUNITY, MUCOSAL; MALE; MICE; MICE, INBRED BALB C; PEYER'S PATCHES; PROTEINS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SPLEEN; T-LYMPHOCYTE SUBSETS; TH1-TH2 BALANCE;

EID: 84883413108     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/1751-2980.12068     Document Type: Article

References (35)

1. Korzenik JR. Is Crohn's disease due to defective immunity? Gut 2007; 56: 2-5.
2. Eckmann L. Animal models of inflammatory bowel disease: lessons from enteric infections. Ann N Y Acad Sci 2006; 1072: 28-38.
3. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990; 98: 694-702.
4. Kraus TA, Mayer L. Oral tolerance and inflammatory bowel disease. Curr Opin Gastroenterol 2005; 21: 692-696.
5. Weiner HL, Mackin GA, Matsui M etal. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 1993; 259: 1321-1324.
6. Maron R, Guerau-de-Arellano M, Zhang X, Weiner HL. Oral administration of insulin to neonates suppresses spontaneous and cyclophosphamide induced diabetes in the NOD mouse. J Autoimmun 2001; 16: 21-28.
7. Eaton AD, Xu D, Garside P. Administration of exogenous interleukin-18 and interleukin-12 prevents the induction of oral tolerance. Immunology 2003; 108: 196-203.
8. Dasgupta A, Kesari KV, Ramaswamy KK, Amenta PS, Das KM. Oral administration of unmodified colonic but not small intestinal antigens protects rats from hapten-induced colitis. Clin Exp Immunol 2001; 125: 41-47.
9. Dieleman LA, Palmen MJ, Akol H etal. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol 1998; 114: 385-391.
10. López MC, Márquez MG, Slobodianik NH, Roux ME. Oral tolerance to dextrin mediated by specific suppressor T-cells induced in the intestinal intraepithelium and their systemic migration. Lymphology 2003; 36: 26-38.
11. Elson CO, Beagley KW, Sharmanov AT etal. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance. J Immunol 1996; 157: 2174-2185.
12. Kraus TA, Toy L, Chan L, Childs J, Mayer L. Failure to induce oral tolerance to a soluble protein in patients with inflammatory bowel disease. Gastroenterology 2004; 126: 1771-1778.
13. Myers LK, Higgins GC, Finkel TH etal. Juvenile arthritis and autoimmunity to type II collagen. Arthritis Rheum 2001; 44: 1775-1781.
14. Margalit M, Israeli E, Shibolet O etal. A double-blind clinical trial for treatment of Crohn's disease by oral administration of Alequel, a mixture of autologous colon-extracted proteins: a patient-tailored approach. Am J Gastroenterol 2006; 101: 561-568.
15. Dasgupta A, Ramaswamy K, Giraldo J, Taniguchi M, Amenta PS, Das KM. Colon epithelial cellular protein induces oral tolerance in the experimental model of colitis by trinitrobenzene sulfonic acid. J Lab Clin Med 2001; 138: 257-269.
16. Gotsman I, Shlomai A, Alper R, Rabbani E, Engelhardt D, Ilan Y. Amelioration of immune-mediated experimental colitis: tolerance induction in the presence of preexisting immunity and surrogate antigen bystander effect. J Pharmacol Exp Ther 2001; 297: 926-932.
17. Song F, Guan Z, Gienapp IE, Shawler T, Benson J, Whitacre CC. The thymus plays a role in oral tolerance in experimental autoimmune encephalomyelitis. J Immunol 2006; 177: 1500-1509.
18. Ohman L, Aström RG, Hultgren Hörnquist E. Impaired B cell responses to orally administered antigens in lamina propria but not Peyer's patches of Gαi2-deficient mice prior to colitis. Immunology 2005; 115: 271-278.
19. + T cells mediating skin inflammation. Blood 2003; 102: 3295-3301.
20. Rizzo LV, Morawetz RA, Miller-Rivero NE etal. IL-4 and IL-10 are both required for the induction of oral tolerance. J Immunol 1999; 162: 2613-2622.
21. Dohi T, Fujihashi K, Koga T etal. T helper type-2 cells induce ileal villus atrophy, goblet cell metaplasia, and wasting disease in T cell-deficient mice. Gastroenterology 2003; 124: 672-682.
22. Dohi T, Fujihashi K, Rennert PD, Iwatani K, Kiyono H, McGhee JR. Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses. J Exp Med 1999; 189: 1169-1180.
23. Yazdanbakhsh M, Kremsner PG, van Ree R. Allergy, parasites, and the hygiene hypothesis. Science 2002; 296: 490-494.
24. Bentwich Z, Weisman Z, Moroz C, Bar-Yehuda S, Kalinkovich A. Immune dysregulation in Ethiopian immigrants in Israel: relevance to helminth infections? Clin Exp Immunol 1996; 103: 239-243.
25. Elliott DE, Setiawan T, Metwali A, Blum A, Urban JF Jr, Weinstock JV. Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. Eur J Immunol 2004; 34: 2690-2698.
26. Gonnella PA, Waldner HP, Weiner HL. B cell-deficient (μMT) mice have alterations in the cytokine microenvironment of the gut-associated lymphoid tissue (GALT) and a defect in the low dose mechanism of oral tolerance. J Immunol 2001; 166: 4456-4464.
27. Carvalho CR, Lenzi HL, Correa-Oliveira R, Vaz NM. Indirect effects of oral tolerance to ovalbumin interfere with the immune responses triggered by Schistosoma mansoni eggs. Braz J Med Biol Res 2002; 35: 1195-1199.
28. Xu Y, Kapp JA γδ T cells are critical for the induction of anterior chamber-associated immune deviation. Immunology 2001; 104: 142-148.
29. Ke Y, Pearce K, Lake JP, Ziegler HK, Kapp JA. γδ T lymphocytes regulate the induction and maintenance of oral tolerance. J Immunol 1997; 158: 3610-3618.
30. Kapp JA, Kapp LM, McKenna KC, Lake JP. γδ T-cell clones from intestinal intraepithelial lymphocytes inhibit development of CTL responses ex vivo. Immunology 2004; 111: 155-164.
31. McMenamin C, McKersey M, Kühnlein P, Hünig T, Holt PG. γδ T cells down-regulate primary IgE responses in rats to inhaled soluble protein antigens. J Immunol 1995; 154: 4390-4394.
32. Gardine CA, Kouki T, DeGroot L. Characterization of the T lymphocyte subsets and lymphoid populations involved in the induction of low-dose oral tolerance to human thyroglobulin. Cell Immunol 2001; 212: 1-15.
33. Hänninen A, Harrison LC. γδ T cells as mediators of mucosal tolerance: the autoimmune diabetes model. Immunol Rev 2000; 173: 109-119.
34. Tsuchiya T, Fukuda S, Hamada H etal. Role of γδT cells in the inflammatory response of experimental colitis mice. J Immunol 2003; 171: 5507-5513.
35. Siegmund B, Sennello JA, Lehr HA, Senaldi G, Dinarello CA, Fantuzzi G. Frontline: interferon regulatory factor-1 as a protective gene in intestinal inflammation: role of TCR γδ T cells and interleukin-18-binding protein. Eur J Immunol 2004; 34: 2356-2364.